Cargando…
Smac-mimetics reduce numbers and viability of human osteoclasts
Elevated activity of bone-degrading osteoclasts (OC) contributes to pathological bone degradation in diseases such as multiple myeloma. Several proinflammatory cytokines, including TNF, contribute to osteoclastogenesis. The receptor-interacting protein kinase 1 (RIPK1) regulates inflammation and cel...
Autores principales: | Moen, Ingrid Nyhus, Westhrin, Marita, Håland, Erling, Haug, Markus, Nonstad, Unni, Klaharn, Merisa, Standal, Therese, Starheim, Kristian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895921/ https://www.ncbi.nlm.nih.gov/pubmed/33608503 http://dx.doi.org/10.1038/s41420-021-00415-1 |
Ejemplares similares
-
TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma
por: Håland, Erling, et al.
Publicado: (2022) -
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan
por: Håland, Erling, et al.
Publicado: (2021) -
Future Therapeutic Directions for Smac-Mimetics
por: Morrish, Emma, et al.
Publicado: (2020) -
New light on Smac mimetics and breast cancer
por: Cornmark, L, et al.
Publicado: (2016) -
Hyperosmotic stress enhances cytotoxicity of SMAC mimetics
por: Bittner, Sebastian, et al.
Publicado: (2017)